Center for Healthcare Delivery Science, Nemours Children's Health, Orlando, FL, USA.
Division of Endocrinology, Children's National Hospital, Washington, DC, USA.
Int J Behav Med. 2024 Feb;31(1):64-74. doi: 10.1007/s12529-023-10159-0. Epub 2023 Feb 6.
This study aims to examine the relationship between parents' fear of hypoglycemia (FH) over a 1-year period and child glucose metrics in 126 families of youth recently diagnosed with type 1 diabetes (T1D).
Parents completed the Hypoglycemia Fear Survey for Parents (HFS-P) and uploaded 14 days of glucose data at a baseline, 6-month, and 12-month assessment.
Parents' HFS-P total and worry scores increased to a clinically meaningful degree from baseline to 6-month assessment, while multilevel models revealed within- and between-person variability in parents' HFS-P worry and behavior scores over time associated with child glycemia. Specifically, a significant negative relationship for within-person worry scores suggested that when parents reported higher than their average worry scores, their children recorded fewer glucose values in the target range, while within-person behavior scores suggested that when parents reported lower than their average behavior scores, their children recorded more values above the target range. There was also a negative relationship for between-person behavior scores with child glycated hemoglobin and a positive relationship for between-person behavior scores with child glucose values in the target range.
In the recent-onset period of T1D, parental FH worry and behavior associated with child glycemia possibly due to changes in parents' perceptions of their child's hypoglycemia risk. The clinically meaningful increases in parent FH in the recent-onset period and the negative association for between-person behavior scores with child glycated hemoglobin suggest that clinics should consider screening parents for FH, especially among parents of children with lower glycemic levels.
本研究旨在探讨在 126 个近期被诊断为 1 型糖尿病(T1D)的青少年家庭中,父母在 1 年内对低血糖的恐惧(FH)与儿童血糖指标之间的关系。
父母完成了父母低血糖恐惧量表(HFS-P)并在基线、6 个月和 12 个月评估时上传了 14 天的血糖数据。
父母的 HFS-P 总分和担忧评分从基线到 6 个月评估时呈显著增加,达到临床有意义的程度,而多层次模型显示父母的 HFS-P 担忧和行为评分随时间具有个体内和个体间的变异性,与儿童血糖有关。具体而言,个体内担忧评分呈显著负相关,表明当父母报告的担忧评分高于平均水平时,他们的孩子记录的目标范围内的血糖值较少,而个体内行为评分表明当父母报告的行为评分低于平均水平时,他们的孩子记录的目标范围以上的血糖值更多。个体间行为评分与儿童糖化血红蛋白呈负相关,个体间行为评分与儿童目标范围内的血糖值呈正相关。
在 T1D 的近期发病期,父母的 FH 担忧和行为与儿童的血糖有关,这可能是由于父母对孩子低血糖风险的看法发生了变化。近期发病期父母 FH 显著增加,以及个体间行为评分与儿童糖化血红蛋白呈负相关,表明临床应考虑筛查 FH,特别是在血糖水平较低的儿童的父母中。